Inovexus, a Paris-based venture capital (VC) firm, is aiming to begin deployment via its new early growth fund, CEO and founder Philippe Roche said.
Buyer adds cosmetic surgery chain to portfolio of healthcare assets; is targeting IPO on Nordic Growth markets
Flexible remit allows EUR 2bn vehicle to invest through macroeconomic uncertainty
Fund-of-funds has made two investments to date and plans to attract further European institutional LPs
Acquisition of the Swedish customer and employee feedback platform follows a Houlihan Lokey-led sale process